A-to-Z enrolled @ subjects after ACS and randomized them to a high-potency ( simvastatin @ mg/day @ months , then simvastatin @ mg/day ) versus a delayed moderate-potency statin strategy ( placebo @ months , then simvastatin @ mg/day ) .